Five postdoctoral research scientists and two associate research scientists who work in Columbia medical and dental school labs took home honors at this year’s Postdoctoral Research Symposium.
Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
An experimental gel developed by arthritis researchers at Columbia's College of Dental Medicine can reduce osteoarthritis in animals when injected into the joints.
A mechanism used by adult zebrafish to create new neurons in the brain is dormant in people; reawakening it might repair our brains and slow Alzheimer’s disease.
A study led by Columbia neurosurgeons has found that MRI-guided laser ablation is a viable treatment that can provide lasting seizure control for people with drug-resistant temporal lobe epilepsy.
Grants management expert Jaime Rubin, PhD, is sharing her expertise in Kosovo to help the government develop systems and programs to best support the country's researchers.
Many researchers believe that the neurodegenerative disorder gets started in the gut. Columbia research now suggests that an autoimmune reaction may be driving those early events.
Columbia researchers have identified brain circuits that, when injured, make conscious patients with acute brain injury appear unresponsive, a phenomenon known as hidden consciousness.
Members of a task force met with researchers, school research leadership, and research leaders from other academic medical centers to identify ways to strengthen computing and IT resources at CUIMC.